- Home
- SNFCA vs ADAG Comparison
SNFCA vs ADAG Comparison
Compare SNFCA & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNFCA | ADAG |
|---|---|---|
| Founded | 1965 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 239.3M | 222.2M |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SNFCA | ADAG |
|---|---|---|
| Price | $9.09 | $2.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $9.91 |
| AVG Volume (30 Days) | 20.2K | ★ 365.5K |
| Earning Date | 11-12-2026 | 08-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.51 | N/A |
| EPS | ★ 0.60 | N/A |
| Revenue | ★ $344,587,538.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $129.59 |
| P/E Ratio | $14.82 | ★ N/A |
| Revenue Growth | ★ 3.01 | N/A |
| 52 Week Low | $7.70 | $1.30 |
| 52 Week High | $10.23 | $4.85 |
Technical Indicators
Market Signals| Indicator | SNFCA | ADAG |
|---|---|---|
| Relative Strength Index (RSI) | 54.35 | 40.09 |
| Support Level | $8.56 | N/A |
| Resistance Level | $9.39 | $3.50 |
| Average True Range (ATR) | 0.20 | 0.25 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 63.08 | 39.38 |
Price Performance
Historical ComparisonAbout SNFCA Security National Financial Corporation
Security National Financial Corp is a holding company providing insurance services. The company operates in three reportable business segments: Life insurance, Cemetery and Mortuary, and Mortgages. The life insurance segment sells and services selected lines of life insurance, annuity products, and accident and health insurance. The cemetery and mortuary segment engages in pre-need selling of funeral, cemetery, mortuary, and cremation services through its cemetery and mortuary locations. The mortgage segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and other real estate projects. It derives the majority of revenue from Life Insurance segment.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.